CN111653335A - Remaining drug dosage time-of-use identification system - Google Patents
Remaining drug dosage time-of-use identification system Download PDFInfo
- Publication number
- CN111653335A CN111653335A CN202010566855.6A CN202010566855A CN111653335A CN 111653335 A CN111653335 A CN 111653335A CN 202010566855 A CN202010566855 A CN 202010566855A CN 111653335 A CN111653335 A CN 111653335A
- Authority
- CN
- China
- Prior art keywords
- medicine
- equipment
- time
- patient
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 117
- 229940079593 drug Drugs 0.000 title claims abstract description 40
- 238000000889 atomisation Methods 0.000 claims abstract description 37
- 230000007246 mechanism Effects 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 28
- 238000004458 analytical method Methods 0.000 claims abstract description 8
- 238000001514 detection method Methods 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000007921 spray Substances 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 2
- 239000013307 optical fiber Substances 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000002664 inhalation therapy Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000006199 nebulizer Substances 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
- G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
- G06V40/16—Human faces, e.g. facial parts, sketches or expressions
- G06V40/161—Detection; Localisation; Normalisation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Physics & Mathematics (AREA)
- Multimedia (AREA)
- Theoretical Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Human Computer Interaction (AREA)
- Physics & Mathematics (AREA)
- Primary Health Care (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention relates to a remaining drug dose time of use identification system, the system includes: a dose detection device, provided in the medicine container, for detecting a remaining dose of a liquid medical medicine in the medicine container; the dosage identification device is positioned in the atomization treatment mechanism and used for receiving the current ultrasonic atomization intensity in the atomization treatment mechanism and determining the dosage of the liquid medical medicine in the medicine container consumed in unit time in direct proportion to the current ultrasonic atomization intensity; and the time analysis equipment is used for obtaining the available time of the medicine. The residual medicine dosage time-use identification system provided by the invention is stable in operation and timely in reminding. Because the usable time of the residual medicine and whether the medicine is mistaken or not can be identified on site based on the use state of the ultrasonic atomizer, effective reference data are provided for maintaining the normal use of the ultrasonic atomizer.
Description
Technical Field
The invention relates to the field of atomization treatment, in particular to a time-use identification system for residual medicine dosage.
Background
Aerosol therapy refers primarily to aerosol inhalation therapy. Aerosol refers to fine solid or liquid particles suspended in air. Therefore, the aerosol inhalation therapy is to disperse the medicine into tiny droplets or particles by using an atomizing device, suspend the particles in the air and enter a breathing passage and a lung so as to achieve the purposes of cleaning the air passage, humidifying the air passage, local treatment and whole-body treatment.
The pharmacokinetics of inhaled drugs have a significant impact on aerosol inhalation therapy. If the aerosol inhalation aims to locally generate therapeutic action in the lung, drugs (such as corticoids) which are inhaled into the airway and have high local bioactivity and are quickly inactivated after being absorbed to the whole body are selected. If the medicine is only absorbed through the air passage and acts on other parts of the whole body, the medicine with better absorption of the respiratory mucosa and low local metabolic rate is selected.
For patients with mechanical ventilation of the artificial airway, the placement of the aerosol generating device 30cm from the patient's endotracheal tube increases the rate of aerosol deposition in the lungs, since the ventilator air delivery conduit acts as a reservoir (spacer) that accumulates aerosol particles.
Disclosure of Invention
In order to solve the technical problems in the related art, the invention provides a residual medicine dosage time identification system which can identify the available time of residual medicines and whether the medicines are mistakenly used or not on site based on the use state of an ultrasonic atomizer, so that effective reference data are provided for maintaining normal use of the ultrasonic atomizer.
Therefore, the invention at least needs to have the following three key points:
(1) detecting the residual dosage of the liquid medical medicine in the medicine container of the atomization treatment mechanism in real time, receiving the current ultrasonic atomization intensity in the atomization treatment mechanism at the same time, and determining the dosage of the liquid medical medicine in the medicine container consumed in unit time in direct proportion to the current ultrasonic atomization intensity;
(2) dividing the remaining dose of liquid medical drug by the dose of liquid medical drug in the drug container consumed per unit time to obtain the usable time of the remaining drug;
(3) and searching the name of the corresponding used medicine based on the number identification result of the patient wearing the atomization treatment mechanism at present and projecting in real time to avoid using the wrong atomized medicine.
According to an aspect of the present invention, there is provided a remaining drug dose time identification system, the system comprising:
a dose detection device, provided in the medicine container, for detecting a remaining dose of a liquid medical medicine in the medicine container;
the dosage identification device is positioned in the atomization treatment mechanism and used for receiving the current ultrasonic atomization intensity in the atomization treatment mechanism and determining the dosage of the liquid medical medicine in the medicine container consumed in unit time in direct proportion to the current ultrasonic atomization intensity;
time analysis equipment which is respectively connected with the dose detection equipment and the dosage identification equipment and is used for dividing the residual dose by the dose of the liquid medical medicine in the medicine container consumed in unit time so as to obtain available medicine time;
the atomization treatment mechanism adopts a head wearing mode and is used for sleeving the head of a patient to provide different spray treatment operations of liquid medical medicines for the patient;
the atomization treatment mechanism comprises a wearable hood, a medicine container, a medical pipeline and an ultrasonic generator, wherein the medical pipeline leads to the medicine container;
the embedded camera is embedded in the atomization treatment mechanism and used for carrying out camera shooting operation on the head of the patient facing the embedded camera so as to obtain a corresponding head image of the patient;
the real-time sharpening mechanism is connected with the embedded camera and is used for carrying out sharpening processing based on a Roberts operator on the received patient head image so as to obtain a corresponding current sharpened image;
the signal identification device is positioned on the atomization treatment mechanism and used for carrying out identification operation on the largest area of the face region in the current sharpened image so as to obtain a corresponding patient number;
the data conversion equipment is connected with the signal identification equipment and used for searching the name of more than one liquid medical medicine corresponding to the received patient number in a medical medicine database to be output as a field medicine name;
and the instant projection mechanism is connected with the data conversion equipment and is used for projecting the received field medicine name to the front area of the head of the patient so as to realize instant reminding operation on the patient and medical staff.
The residual medicine dosage time-use identification system provided by the invention is stable in operation and timely in reminding. Because the usable time of the residual medicine and whether the medicine is mistaken or not can be identified on site based on the use state of the ultrasonic atomizer, effective reference data are provided for maintaining the normal use of the ultrasonic atomizer.
Detailed Description
An embodiment of the remaining drug dose time identification system of the present invention will be described in detail below.
The ultrasonic atomizer is used for atomization equipment in medical treatment, and the basic principle is as follows: the oscillating signal from the main circuit board is subjected to energy amplification by the high-power triode and transmitted to the ultrasonic wafer, the ultrasonic wafer converts electric energy into ultrasonic energy, the ultrasonic energy can atomize the water-soluble medicine into 1-5 um tiny fog particles at normal temperature, water is used as a medium, the water-soluble liquid medicine is sprayed into fog by utilizing ultrasonic directional pressure, the liquid medicine is sprayed into an air passage of a patient by means of wind power of an internal fan, and then the liquid medicine is inhaled by the patient and directly acts on a focus, and the ultrasonic medical ultrasonic.
The ultrasonic atomizer breaks up the liquid water molecule structure to generate natural and elegant water mist through the high-frequency resonance of the ceramic atomizing sheet by utilizing the electronic high-frequency oscillation (the oscillation frequency is 1.7MHz or 2.4MHz, which exceeds the hearing range of people, and the electronic oscillation has no harm to human bodies and animals), and does not need to be heated or added with any chemical reagent. Compared with the heating atomization mode, the energy is saved by 90 percent. In addition, a large amount of negative ions are released in the atomization process and generate electrostatic reaction with smoke, dust and the like floating in the air, so that the negative ions are precipitated, and meanwhile, harmful substances such as formaldehyde, carbon monoxide, bacteria and the like can be effectively removed, so that the air is purified, and the occurrence of diseases is reduced.
At present, in the use of wear-type ultrasonic nebulizer, because the patient who adopts the aerosol therapy is numerous and medical personnel's quantity is relatively limited, can't effectively ensure that every patient who adopts the aerosol therapy whether used the medicine that the accurate pharmacy is symptomatic, also can't judge the remaining medicine usable time of current ultrasonic nebulizer, lead to reliability and the security of ultrasonic nebulizer can't obtain effective guarantee.
In order to overcome the defects, the invention builds a residual medicine dosage time-use identification system, and can effectively solve the corresponding technical problem.
A remaining drug dose time of use identification system shown according to an embodiment of the present invention includes:
a dose detection device, provided in the medicine container, for detecting a remaining dose of a liquid medical medicine in the medicine container;
the dosage identification device is positioned in the atomization treatment mechanism and used for receiving the current ultrasonic atomization intensity in the atomization treatment mechanism and determining the dosage of the liquid medical medicine in the medicine container consumed in unit time in direct proportion to the current ultrasonic atomization intensity;
time analysis equipment which is respectively connected with the dose detection equipment and the dosage identification equipment and is used for dividing the residual dose by the dose of the liquid medical medicine in the medicine container consumed in unit time so as to obtain available medicine time;
the atomization treatment mechanism adopts a head wearing mode and is used for sleeving the head of a patient to provide different spray treatment operations of liquid medical medicines for the patient;
the atomization treatment mechanism comprises a wearable hood, a medicine container, a medical pipeline and an ultrasonic generator, wherein the medical pipeline leads to the medicine container;
the embedded camera is embedded in the atomization treatment mechanism and used for carrying out camera shooting operation on the head of the patient facing the embedded camera so as to obtain a corresponding head image of the patient;
the real-time sharpening mechanism is connected with the embedded camera and is used for carrying out sharpening processing based on a Roberts operator on the received patient head image so as to obtain a corresponding current sharpened image;
the signal identification device is positioned on the atomization treatment mechanism and used for carrying out identification operation on the largest area of the face region in the current sharpened image so as to obtain a corresponding patient number;
the data conversion equipment is connected with the signal identification equipment and used for searching the name of more than one liquid medical medicine corresponding to the received patient number in a medical medicine database to be output as a field medicine name;
and the instant projection mechanism is connected with the data conversion equipment and is used for projecting the received field medicine name to the front area of the head of the patient so as to realize instant reminding operation on the patient and medical staff.
Next, the detailed configuration of the remaining medicine dose use identification system of the present invention will be further described.
The time-of-use identification system for the residual drug dose comprises:
the medical drug database stores each patient number inputted by medical staff and the name of more than one liquid medical drug corresponding to the patient number.
The time-of-use identification system for the residual drug dose comprises:
the instant projection mechanism is further connected with the time analysis equipment and used for receiving the medicine available time and projecting the medicine available time.
The remaining drug dosage time-of-use identification system may further include:
and the EDO DRAM chip is arranged at the far end of the data conversion equipment, is connected with the data conversion equipment through a network and is used for storing the medical drug database.
The remaining drug dosage time-of-use identification system may further include:
and the humidity sensing equipment is arranged on the left side of the data conversion equipment and is used for measuring the field humidity of the current position of the data conversion equipment.
The remaining drug dosage time-of-use identification system may further include:
the parameter judgment device is connected with the humidity sensing device and used for sending a humidity alarm signal when the received field humidity exceeds the limit;
and the humidity analysis equipment is also used for sending a humidity reliable signal when the received field humidity is not over-limit.
The remaining drug dosage time-of-use identification system may further include:
and the field notification equipment is connected with the parameter judgment equipment and is used for executing corresponding alarm operation when receiving the humidity alarm signal.
The time-of-use identification system for the residual drug dose comprises:
the on-site notification equipment is a buzzer and is used for sending out buzzing sound with preset frequency when corresponding alarm operation is executed;
or the field notification equipment is a voice playing chip and is used for playing a corresponding alarm file when corresponding alarm operation is executed;
or the field notification equipment is display equipment and is used for displaying corresponding alarm characters when corresponding alarm operation is executed.
The remaining drug dosage time-of-use identification system may further include:
and the optical fiber communication interface is connected with the field notification device and is used for receiving and transmitting the on-off state of the field notification device.
In addition, the EDO (extended Data out) DRAM is 5% faster than the FPM because a logic circuit is provided in the EDO, whereby the EDO can read the next Data into the memory before the previous memory Data read is finished. EDODRAM designed as system memory is inherently very expensive, and is widely used in fifth generation PCs simply because the PC market is demanding a replacement for FPMDRAM. The EDO video memory can work at 75MHz or higher, but the standard working frequency is 66MHz, but the speed cannot meet the requirement of a display chip.
It should be understood that portions of the present invention may be implemented in hardware, software, firmware, or a combination thereof. In the above embodiments, the various steps or methods may be implemented in software or firmware stored in memory and executed by a suitable instruction execution system. For example, if implemented in hardware, as in another embodiment, any one or combination of the following techniques, which are known in the art, may be used: a discrete logic circuit having a logic gate circuit for implementing a logic function on a data signal, an application specific integrated circuit having an appropriate combinational logic gate circuit, a Programmable Gate Array (PGA), a Field Programmable Gate Array (FPGA), or the like.
It will be understood by those skilled in the art that all or part of the steps carried by the method for implementing the above embodiments may be implemented by hardware related to instructions of a program, which may be stored in a computer readable storage medium, and when the program is executed, the program includes one or a combination of the steps of the method embodiments.
The storage medium mentioned above may be a read-only memory, a magnetic or optical disk, etc. Although embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting the present invention, and that variations, modifications, substitutions and alterations can be made to the above embodiments by those of ordinary skill in the art within the scope of the present invention.
Claims (9)
1. A system for identifying remaining drug doses upon use, comprising:
a dose detection device, provided in the medicine container, for detecting a remaining dose of a liquid medical medicine in the medicine container;
the dosage identification device is positioned in the atomization treatment mechanism and used for receiving the current ultrasonic atomization intensity in the atomization treatment mechanism and determining the dosage of the liquid medical medicine in the medicine container consumed in unit time in direct proportion to the current ultrasonic atomization intensity;
time analysis equipment which is respectively connected with the dose detection equipment and the dosage identification equipment and is used for dividing the residual dose by the dose of the liquid medical medicine in the medicine container consumed in unit time so as to obtain available medicine time;
the atomization treatment mechanism adopts a head wearing mode and is used for sleeving the head of a patient to provide different spray treatment operations of liquid medical medicines for the patient;
the atomization treatment mechanism comprises a wearable hood, a medicine container, a medical pipeline and an ultrasonic generator, wherein the medical pipeline leads to the medicine container;
the embedded camera is embedded in the atomization treatment mechanism and used for carrying out camera shooting operation on the head of the patient facing the embedded camera so as to obtain a corresponding head image of the patient;
the real-time sharpening mechanism is connected with the embedded camera and is used for carrying out sharpening processing based on a Roberts operator on the received patient head image so as to obtain a corresponding current sharpened image;
the signal identification device is positioned on the atomization treatment mechanism and used for carrying out identification operation on the largest area of the face region in the current sharpened image so as to obtain a corresponding patient number;
the data conversion equipment is connected with the signal identification equipment and used for searching the name of more than one liquid medical medicine corresponding to the received patient number in a medical medicine database to be output as a field medicine name;
and the instant projection mechanism is connected with the data conversion equipment and is used for projecting the received field medicine name to the front area of the head of the patient so as to realize instant reminding operation on the patient and medical staff.
2. The residual drug dose time of use identification system of claim 1, wherein:
the medical drug database stores each patient number inputted by medical staff and the name of more than one liquid medical drug corresponding to the patient number.
3. The residual drug dose time identification system of claim 2, wherein:
the instant projection mechanism is further connected with the time analysis equipment and used for receiving the medicine available time and projecting the medicine available time.
4. The residual drug dose age identification system of claim 3, further comprising:
and the EDO DRAM chip is arranged at the far end of the data conversion equipment, is connected with the data conversion equipment through a network and is used for storing the medical drug database.
5. The residual drug dose age identification system of claim 4, further comprising:
and the humidity sensing equipment is arranged on the left side of the data conversion equipment and is used for measuring the field humidity of the current position of the data conversion equipment.
6. The residual drug dose age identification system of claim 5, further comprising:
the parameter judgment device is connected with the humidity sensing device and used for sending a humidity alarm signal when the received field humidity exceeds the limit;
and the humidity analysis equipment is also used for sending a humidity reliable signal when the received field humidity is not over-limit.
7. The residual drug dose age identification system of claim 6, further comprising:
and the field notification equipment is connected with the parameter judgment equipment and is used for executing corresponding alarm operation when receiving the humidity alarm signal.
8. The residual drug dose time identification system of claim 7, wherein:
the on-site notification equipment is a buzzer and is used for sending out buzzing sound with preset frequency when corresponding alarm operation is executed;
or the field notification equipment is a voice playing chip and is used for playing a corresponding alarm file when corresponding alarm operation is executed;
or the field notification equipment is display equipment and is used for displaying corresponding alarm characters when corresponding alarm operation is executed.
9. The residual drug dose age identification system of claim 8, further comprising:
and the optical fiber communication interface is connected with the field notification device and is used for receiving and transmitting the on-off state of the field notification device.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010566855.6A CN111653335A (en) | 2020-06-19 | 2020-06-19 | Remaining drug dosage time-of-use identification system |
| GBGB2015261.7A GB202015261D0 (en) | 2020-06-19 | 2020-09-28 | Remaining drug dosage time identification system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010566855.6A CN111653335A (en) | 2020-06-19 | 2020-06-19 | Remaining drug dosage time-of-use identification system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111653335A true CN111653335A (en) | 2020-09-11 |
Family
ID=72348053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010566855.6A Withdrawn CN111653335A (en) | 2020-06-19 | 2020-06-19 | Remaining drug dosage time-of-use identification system |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN111653335A (en) |
| GB (1) | GB202015261D0 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112773981A (en) * | 2021-01-28 | 2021-05-11 | 深圳麦科田生物医疗技术股份有限公司 | Automatic dressing change atomizing device |
| CN113155662A (en) * | 2021-03-30 | 2021-07-23 | 湘潭市计量测试检定所 | Method for detecting residual liquid volume of medical compression atomizer |
| CN113694325A (en) * | 2021-08-09 | 2021-11-26 | 常州工学院 | Intelligent liquid medicine cup for atomizer |
| WO2022160197A1 (en) * | 2021-01-28 | 2022-08-04 | 深圳麦科田生物医疗技术股份有限公司 | Automatic medicine replacement and atomization device |
-
2020
- 2020-06-19 CN CN202010566855.6A patent/CN111653335A/en not_active Withdrawn
- 2020-09-28 GB GBGB2015261.7A patent/GB202015261D0/en not_active Ceased
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112773981A (en) * | 2021-01-28 | 2021-05-11 | 深圳麦科田生物医疗技术股份有限公司 | Automatic dressing change atomizing device |
| WO2022160197A1 (en) * | 2021-01-28 | 2022-08-04 | 深圳麦科田生物医疗技术股份有限公司 | Automatic medicine replacement and atomization device |
| CN113155662A (en) * | 2021-03-30 | 2021-07-23 | 湘潭市计量测试检定所 | Method for detecting residual liquid volume of medical compression atomizer |
| CN113155662B (en) * | 2021-03-30 | 2024-09-13 | 湘潭市计量测试检定所 | Method for detecting residual liquid amount of medical compression atomizer |
| CN113694325A (en) * | 2021-08-09 | 2021-11-26 | 常州工学院 | Intelligent liquid medicine cup for atomizer |
Also Published As
| Publication number | Publication date |
|---|---|
| GB202015261D0 (en) | 2020-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111653335A (en) | Remaining drug dosage time-of-use identification system | |
| CN206198413U (en) | Atomizer breathing control device | |
| US10046123B2 (en) | Systems and methods for administering pulmonary medications | |
| US11273271B2 (en) | Aerosolization system with flow restrictor and feedback device | |
| WO2021185055A1 (en) | Intelligent micro mesh nebulizer and nebulization system | |
| JP2016516537A (en) | Breathing apparatus, related systems, and methods | |
| CN205729927U (en) | Full-automatic breathing self adaptation medical vaporizer | |
| CN205391423U (en) | Portable internal medicine ultrasonic atomization inhaler | |
| Sidler-Moix et al. | Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers | |
| Pitance et al. | Aerosol delivery through tracheostomy tubes: an in vitro study | |
| CN106823079A (en) | A kind of quantitative atomized medicine introducing device of delivery type | |
| CN203507247U (en) | Nebulizer special for mechanical ventilation | |
| CN209347828U (en) | An atomizing spray device | |
| CN113813478B (en) | Automatic control method and system for drug delivery of atomizer | |
| EP0590752A1 (en) | Apparatus and method for producing liquid particles and negative ions | |
| Fink et al. | Nebulizers | |
| CN110975077A (en) | Medical atomizer | |
| CN109745601B (en) | Atomization process monitoring method, system, computer equipment, storage medium and device | |
| Perumal et al. | Intelligent airflow of nebulizer using IoT-based circuit integration for smart healthcare management | |
| CN219148837U (en) | A nebulization and inhalation nebulization drug delivery device | |
| CN117482338A (en) | Accurate delivery device for delivering drug aerosol and accurate drug administration control method | |
| CN216496899U (en) | Atomizer | |
| CN212327124U (en) | Multifunctional Compression Nebulizer | |
| CN212651186U (en) | A kind of atomizing device for preventing aerosol pollution | |
| CN113952562A (en) | Atomizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200911 |
|
| WW01 | Invention patent application withdrawn after publication |